A structure-function characterization of the ER membrane protein atlastin by Moss, Tyler J.
RICE UNIVERSITY 
A structure-function characterization of the ER membrane 
protein atlastin 
by 
Tyler J Moss 
A THESIS SUBMITTED 
IN PARTIAL FULFILLMENT OF THE 
REQUIREMENTS FOR THE DEGREE 
Doctor of Philosophy 
OVED, THESIS C'J_ITTEE 
Dr James A. Me w, Associate Professor 
o Biochemistry & Cell Biology 
Dr. Huey W. Huang, Sam and Helen 
Worden Professor of Physics and 
Astronomy 
HOUSTON, TEXAS 
OCTOBER 2011 
Abstract 
A structure-function characterization of the ER membrane 
protein atlastin 
by 
Tyler Moss 
The biogenesis and maintenance of the entire endomembrane system is 
dependent upon membrane fusion proteins. Mounting evidence indicates that the 
integral membrane GTPase Atlastin is a membrane fusion protein involved in the 
homotypic fusion of the endoplasmic reticulum (ER) membrane suggesting a role in 
the biogenesis and maintenance of ER structure. I helped show that recombinant 
Drosophila atlastin is able to promote the fusion of synthetic membranes in vitro 
and that this fusion is dependent upon atlastin GTPase activity. The structure-
function experiments presented here assist in elucidating domains required in the 
mechanism of atlastin mediated membrane fusion. ER homotypic fusion is 
dependent upon the self-association of Atlastin subunits in adjacent membranes to 
bring the bilayers into close molecular contact. Atlastin dimerization occurs in the 
presence of GTPyS but not GDP and stable dimerization is dependent upon a 
juxtamembrane middle domain three-helix bundle (3HB). The atlastin GTPase 
domain and 3HB form a potent soluble domain inhibitor of atlastin homotypic 
fusion, while the GTPase domain alone shows little inhibition. Designed GTPase 
domain mutations show that GTP binding and atlastin dimerization is insufficient to 
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support fusion without GTP hydrolysis. Additionally, domain analysis of atlastin 
reveals that the C-terminal cytoplasmic domain of atlastin is absolutely required for 
membrane fusion, possibly through a protein-lipid interaction of an amphipathic 
alpha-helix. Genetic lesions in the human Atlastin-1 gene, SPG3A, result in a form of 
autosomal dominant hereditary spastic paraplegia (HSP). A better understanding of 
Atlastin function should lend significant insight into normal ER biogenesis and 
maintenance, as well as the pathology of human disease. 
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Chapter 1 
Introduction and Literature Review 
Biological membranes are one of the defining characteristics of living 
organisms and are essential to life. Biological membranes are composed of 
amphipathic lipids that form lipid bilayers spontaneously to protect the 
hydrophobic tails from aqueous solution and expose the polar heads groups to the 
surrounding aqueous environment. Lipid bilayers assume an energetically 
favorable spherical structure forming a semipermeable membrane which defines 
the limits of a cell. Eukaryotic organisms also have intracellular membranous 
compartments. The formation and maintenance of these compartments and 
transfer of compartmental material from one compartment to the next requires 
membrane fusion. The fusion ofbiological membranes is an essential process in all 
eukaryotic cells. All known biological membrane fusion is mediated by specific 
fusion proteins or fusogens. 
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1.1. Biological membrane fusion 
Membrane fusion is defined as the merging of two separate lipid bilayers 
followed by the mixing of their bound aqueous contents. In biological systems 
membrane fusion is not a spontaneous process. There are several energy barriers 
that must be overcome prior to lipid and aqueous content mixing. A significant 
amount of energy input is required in order to displace the water shell surrounding 
the two lipid bilayers, overcome the barriers of electrostatic repulsion between the 
phospholipid polar head groups, and then disrupt two continuous lipid 
monolayers1(Figure 1-1). The high curvature of vesicle membranes can overcome 
some of these energy barriers, but it is apparent that membrane fusion requires 
more than just close membrane apposition2. The remaining energy needed is 
provided by fusion peptides, which are vital to many cellular processes that require 
the fusion of biological membranes3. It has been proposed that all intracellular 
fusion events are mediated by fusion proteins 4. The fusion of biological membranes 
can be divided into three broad categories: viral fusion, cell-cell fusion, and 
intracellular fusion (Figure 1-2). Viral fusion (the fusion of a viral membrane with 
Figure 1-1: Membrane fusion proceeds through hemifusion 
Membrane fusion begins when two membranes are brought into close proximity, followed by the 
mixing of outer-leaflets and fusion stalk formation, expansion of the stalk to form a fusion diaphragm, 
and mixing of inner-leaflets to form fusion pore and mixing of aqueous contents. 
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the host cell membrane) is a necessary part of viral pathogenesis. Cell-cell fusion is 
important in many developmental processes and is necessary for fertilization. The 
last type of fusion, intracellular fusion, is important in many processes that occur 
inside the eukaryotic cell. 
Intracellular fusion included all the fusion events in the secretory and 
endocytic pathways. Other types of intracellular membrane fusion include organelle 
• SNARES • OPA1/MGM1 • Atlastin • HOPS 
• Dysferlin, myoferlin , tricalbin • Synaptotagmin • lg-domain proteins "..> Actin bundles 
A Viral fusion protein • Tethering/regulatory factors • Mitofusin/Fzo1 
Viral fusion 
Yeast cell 
Smooth ER membrane fusion Regulated exocytosis Mitochondrial fusion 
Figure 1-2: The fusion ofbiomembranes is essential to many cellular functions. 
A diagram of two generic cells depicts several cellular processes that require membrane fusion and 
the proteins that mediate the fusion. Electron micrographs show viral-cell (top-left) and cell-cell 
fusion (top-right). Fusion is essential for peripheral ER (bottom left) formation, exocytosis (bottom 
middle) and mitochondrial network formation and maintenance (bottom right). Adapted from 
M::JrtP.ns ::Jnci Mc.M::Jhon f200R) 
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fusion. The biogenesis and maintenance of several organellar structures, such as 
peroxisomes, the endoplasmic reticulum, mitochondria, and vacuoles, requires both 
fusion and fission. 
1.2. Endoplasmic reticulum membrane fusion 
The endoplasmic reticulum (ER) is also a highly dynamic organelle that exists 
as an interconnected network of tubes and sheetsS-7• While ER sheets are mostly 
perinuclear and contiguous with the outer nuclear envelope, peripheral tubular 
extensions of the ER move along microtubule tracks frequently joining together by 
membrane fusion. Regions of the peripheral ER maintain close contact with virtually 
all other cytoplasmic organelles including mitochondria, peroxisomes, chloroplasts, 
Golgi and the plasma membrane. These diverse associations throughout the 
cytoplasm may be one reason the ER is structured as a diffuse network in the cell 
periphery. These extensive connections likely play a functional role in non-vesicular 
transport of ER-synthesized lipids and sterols as well as inter-organelle calcium 
homeostasis. Membrane fusion allows the ER to maintain a dynamic network that 
can quickly change shape and preserve lumen continuity while adapting to the 
changing cytoplasmic environment. 
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a 
- Microtubule Kinesin-type motor CLIMP-63 p22 A atlastin 
Figure 1-3: The formation of three-way junctions in the reticular ER by membrane fusion. 
The reticular morphology of the peripheral ER is formed by the expansion of ER tubules along 
microtubule tracks pulled by kinesin motors (a-b). ER tubule ends come into contact with adjacent 
tubules and protein-mediated fusion occurs to form three-way junctions (c) leading to the overall 
network structure of the peripheral ER. Adapted from Vedrenne (2006). 
The tubular ER forms a dynamic network of interconnected tubules that are 
continuously rearranged through fission and fusion of the ER membrane8. Fusion 
and fission are required to maintain the complex morphology of the ER. As 
membrane tubules extend into the cytoplasm along microtubules, they fuse with 
other tubules to form the reticular morphology of the tubular ER9. BNIP, the p97 
protein complex, and SNARE proteins have been suggested as being responsible for 
the homotypic fusion of ER membranes10,l1, however, none of these proteins exhibit 
the GTPase activity which is necessary for this process12. We, along with others, 
have shown that the ER localized large GTPase atlastin is directly responsible for the 
fusion of ER membranes13,14. 
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1.3. Atlastin 
1.3.1. SPG3A and HSP 
Atlastin is encoded by the human SPG3A (SPastic .Gait or SPastic parapleGia 
3A) locus1s. Mutation of SPG3A is responsible for a form of Hereditary Spastic 
Paraplegia (HSP, also called familial spastic paraparesis or Striimpell-Lorrain 
disease), a group of inherited neurological disorders characterized by progressive 
lower extremity weakness and spasticity16,17. Clinical presentation varies 
significantly with age from very young children to adults as old as 55 years. The 
neuropathological basis for compromised motor function in HSP is likely length 
dependent axonopathy of the corticospinal tract17. Genetic analysis has identified 38 
different loci involved in HSP (SPGl-45)16-ta. All methods of inheritance have been 
reported including autosomal dominant (ADHSP), autosomal recessive (ARHSP) and 
X-linked HSP. ADHSP is by far the most prevalent19. Seventeen HSP loci have been 
identified and their molecular analysis has yielded three main categories of 
potential causation. These gene functions fall into three broad groups including 
intracellular trafficking, mitochondrial function, and axonal pathfinding and 
myelination2o. Over half of all ADHSP cases occur in one of three proteins: Spastin 
(SPAST, SPG4,), Atlastin-1 (ATL1, SPG3A), and receptor expression enhancing 
protein -1 (REEP1, SPG31). Spastin mutations occur in 40-45% of ADHSP21, while 
Atlastin-1 and REEP1 account for 10%22 and 3% respectively. 
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Figure 1-4 Comparison of atlastin orthologs and paralogs. 
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61% 
(a)An annotated multiple sequence alignment (ClustalW) of atlastin (black shading= identical 
residues, gray shading= similar residues). (b) Cladogram of atlastin orthologs and paralogs with 
hGBPl as an outgroup (blue, atlastin-1 isoforms; green, atlastin-2 isoforms; red, atlastin-3 isoforms; 
brown, organisms with single isoforms). (c) Comparison of percent identity between fly atlastin and 
human atlastin isoforms. 
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Molecular analysis of patients with HSP has identified 34 point mutations, 3 
frame shifts and one single amino acid deletion in the A TL1 gene (Table 5- 1 ). All of 
these lesions are dominant alleles and mutations have been identified in all domains 
of the protein. Dominant inheritance suggests that the mutant protein is an either 
dominant loss of function allele due to haploinsufficiency, a gain of function allele, or 
a dominant negative allele. The fact that all of the 38 mutations yield a common 
phenotype strongly argues against a gain of function allele. The most likely 
pathological mechanism is therefore haploinsufficiency or a dominant negative 
protein. 
Human atlastin-1 (Atl1) is a 558 amino acid (63,544 Da) multidomain 
protein (Figure 1-4). It has a short N-terminal domain, followed by a well-conserved 
GTPase domain, a middle domain with that forms a 3-helix bundle (3HB), two 
tandem transmembrane domains and a C-terminal cytoplasmic domain23. The 
original atlastin gene was renamed atlastin-1 following the identification of two 
additional paralogs (atlastin-2 and atlastin-3)23. 
1.3.2. Atlastin subcellular localization 
Several groups have analyzed the relative abundance and subcellular 
distribution of the human atlastins. Antibodies against Atl1 recognize a protein of 
the appropriate size predominantly in human brain, but smaller amounts also in 
other tissues23. Immunocytochemsitry in rat brain sections found strong staining in 
pyramidal cells in layer V of the cerebral cortex and pyramidal neurons in the 
hippocampus. Atll colocalized with the Golgi marker p115, but not with anti-KDEL 
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antibodies that mark the ER suggesting that the Atll was a Golgi resident protein. 
Golgi localization in cultured rat neurons was also suggested by electron microscopy 
and immunogold labeling. Subsequent localization studies24 found that myc-tagged-
Atll and Atll-GFP both strongly co-localized with calreticulin, PDI, and sec61alpha 
in HeLa and NSC34 cells providing evidence for an ER localization. The Golgi marker 
GM130 displayed a distinctly different distribution than Atl1-GFP10. Yet a third 
group localized transfected Atll mainly to the ERin HEK293 cells2s. Localization 
studies of Atl2 and Atl3 found that these paralogs were both localized to the ER26, 
further supporting the growing consensus that atlastins are ER resident proteins. 
1.3.3. Atlastin interacting proteins 
Atll has been shown to associate with Spastin, a microtubule severing 
protein, in some contexts5,6,24, and recent work has also demonstrated that atlastin 
interacts with all of the ER tubule forming proteins in the Reticulon and 
REEP /Yop/DP1 family6,14. An interaction between Atll and spastin has been 
reported by several groups5,6,24,26, but often with contradictory conclusions. An 
unspecified partial coding sequence of Atll was identified in a yeast-two hybrid 
screen with spastin as bait24. GST-pull down experiments suggested that GST full-
length Spastin was able to weakly bind the Myc-tagged N-terminal cytoplasmic 
domain of Atll (myc-AtllllTMD) from cell extracts. Additional two hybrid 
interaction data and GST pull downs found that theN-terminal 80 amino acids of 
spastin were necessary for the spastin-myc-AtllllTMD interaction. Spastin-Atll 
interactions were also probed by coimmunoprecipitation experiments24. Myc-
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spastin and Atll-GFP were co-overexpressed in HEK293T cells and Atl1-GFP 
precipitated with anti GFP antibodies. A very small amount of myc-spastin was 
detected in the precipitates. Surprisingly, however, no association was detected 
when antibodies to native proteins were used for immunoprecipitation. Apparently, 
spastin interaction with atlastin is limited to atlastin-1, since atlastin-2 and atlastin-
3 do not interact with spastin26. 
A second two-hybrid study also identified Atll when spastin was used as bait 
to screen a library 5. Surprisingly, this work found that the C-terminus (residues 
408-558) of Atl1 interacted with full length human Spastin. In vitro experiments 
suggested thatthe GST-Atl1 tail (495-558) retains some cleaved (GST)-Spastin. An 
interaction between full-length HA-tagged spastin and His6-tagged Atll was also 
detected by coimmunoprecipitation from HeLa cells. 
Most recently, an association between three HSP proteins atlastin, spastin 
and REEP1 has been reported6. This work showed that the interaction between 
atlastin and REEP1likely occurs through hydrophobic membrane spanning domains 
of each protein6, similar to the other tubule forming proteins14. A similar 
observation was made for the interaction of spastin with atlastin suggesting that 
region of interaction between these two proteins is theN-terminal transmembrane 
segment of the Ml isoform6 ofspastin and the two tandem TMDs ofatlastin. 
In summary, a substantial but contradicting amount of data suggest that Atl1 
and spastin interact, but the nature and significance of this interaction remains 
obscure. 
27 
1.3.4. Previous work on atlastin 
Atlastin function has been examined also in model organisms, specifically the 
fruit fly Drosophila melanogaster. The Drosophila genome produces a single atlastin 
protein. Drosophila Atlastin is 541 amino acids long and has a predicted molecular 
weight of 60,927 Da (Figure 1). The drosophila atl sequence is highly homologous 
with all three human isoforms ranging between 48-51% identical (61-68% similar) 
over the entire length of the protein. Functional homologs of atlastin are also found 
in yeast (Sey1p) and plants (RHD3) as well14,z7. These proteins share limited 
sequence similarity with human atlastin, yet these GTPases possess a similar 
domain structure and potential function. 
The first phenotypic characterization of atlastin function in Drosophila was 
reported in 2008. Lee et al. identified a P-element insertion in the fly atlastin gene 
(atl1) during a large scale behavioral screen7. These authors noted that this mutant 
was temporarily paralyzed by mechanical shock and classified it as "bang-sensitive". 
Molecular analysis of this P-element insertion indicated that neither transcript from 
the drosophila atlastin gene was made and no protein was produced when fly 
extracts were examined by immunoblotting. This mutant was viable, but sterile due 
to problems with oocyte development. atll/ atll homozygous flies are much 
smaller than their wild type counterparts and have a reduced lifespan, -55% shorter 
than control animals. Behavior abnormalities were examined in undisturbed flies 
and animals that had been exposed to mechanical stress. The stressed animal 
exhibited mobility defects that worsened with age leading the authors to speculate 
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that problems with dopaminergic neurons may be occurring. Examination of 
wildtype and atll brains found that the number dopamineric neurons were reduced 
and the reduction was more pronounced with increasing age. Reintroduction of 
atlastin on a genomic trans gene fragment prevented the loss of these neurons. 
Additionally, selective reexpression in dopamineric neurons using a UAS trans gene 
also improved the loss of mobility ofatll mutants. 
Given the potential importance of the observed age related loss of 
dopamineric neurons in Drosophila to the pathophysiology of HSP, Albin et al.2B 
examined dopaminergic nigrostriatal innervation in SPG3A ADHSP patients, but 
found normal nigrostraital terminal densities in both affected individuals suggesting 
that degeneration of dopamineric neurons is not a common course in humans. This 
observation is also consistent with the clinical presentation of SPG3A ADHSP at an 
early age and slow or no progression. 
More recently, another atlastin mutant (atl2) was generated by imprecise 
excision of the original atll P-element29. No rationale was provided for the 
generation of this new mutant given that their previous report documented that the 
atll P-element insertion was a null allele. Regardless, the new -1,600 bp deletion 
mutant is likely a null alelle and is pupal lethal with -8% adult escaper that are 
sterile. This result strongly suggests that the original P-element insertion (atll) was 
not a null allele and casts doubt on the original observations made with this fly line. 
Immunolocalization experiments found that drosophila atlastin was broadly 
expressed in the larval CNS as well as body wall muscle, but not enriched within 
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synapses. Subcellular localization in muscle found that the majority of fly atlastin 
was localized to the ER, marked by GFP-KDEL. 
Analysis of the atl2 mutant indicated that loss of Atlastin produced subtle 
effects on synaptic bouton number as well as body wall muscle size in wandering 
third instar larvae. Examination of microtubule organization in muscle suggested 
that atlastin may regulate microtubule organization and dynamics, as has been 
suggested by association with spastin. Furthermore, these authors suggest that 
atlastin may also functionally and physically interact with Spastin. Overexpression 
of atlastin in muscle yielded a decrease in the amount of acetylated tubulin detected 
by immunofluorescence and loss of spastin reversed this effect. Finally, in vitro GST 
pull down experiments indicated that a very small amount of myc-tagged atlastin in 
HEK293 cell extracts can be isolated with theN-terminus of Spastin fused to GST. 
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Chapter 2 
Materials and Methods 
2.1. Molecular biology 
2.1.1. Expression vectors 
Prior to expression of recombinant protein I subcloned atlastin and atlastin 
mutants into a modified pGEX-4T-3 vector. To make the modified vector 
complementary, 5'-phosphorylated oligonucleotides ( #594 (5'-TCG AGC ATC ATC 
ATC ATC ATC ATC ATC ACT GAC-3') and #595 (5'-GGC CGT CAG TGA TGA TGA TGA 
TGA TGA TGA TGC-3')) were mixed together and ligated into pGEX-4T-3 cut with 
Xhol and Notl to generate pJM680 (pGEX-4T-3 with a carboxy-terminal acta-
histidine tag). 
An additional expression vector, pGEX-ST, was used for the production of 
untagged proteins. pGEX-ST is a bacterial expression vector that contains anN-
terminal GST -SUMO tag3o. The first 97 residues of SUM0-1 is inserted after the GST 
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sequence and upstream of the Bam HI cut site so that when the expressed protein is 
cut with SENP2 it results in a protein with its native methionine as theN-terminal 
residue. This vector and a plasmid containing the sequence encoding Drosophila 
melanogaster atlastin (1-328) in pGEX-ST (pJM841) was graciously donated by our 
collaborator (Mariko Aryoshi; Kyoto University, Japan). 
2.1.2. Subcloning 
Drosophila melanogaster atlastin was PCR amplified from pGEX-atlastin 
(obtained from Andrea Daga) using the oligonucleotides #583 (5'-CCG GAT CCA TGG 
GCG GAT CGG C-3') and #590 (5'-ATC TCG AGT GAC CGC TTC ACC-3'), digested with 
BamHI and Xhol, and ligated into pJM680 cut with the same enzymes to generate 
pJM681. 
The c-terminal truncations of atlastin were generated by PCR using pJM681 
as a template. The sequences corresponding to atlastin (1-422), pJM704; atlastin 
(1-450), pJM705, atlastin(1-471), pJM706, and atlastin(1-497), pJM813 were 
amplified using the forward oligo #583 and the reverse oligos #611 (5'-ATC TCG 
AGT GTC CGT GCT GCC-3'), #612 (5'-TTC TCG AGG TTG GCG AAC GTA TAG AGA CC-
3'), #613 (5'-CCC TCG AGA TAT CTAATG TAG GCC CAC-3'), and #687 (5'-ATC TCG 
AGG ATG GGT CGC ATG AAT TTC TC-3'), respectively. The PCR product was cut with 
the restriction enzymes BamHI and Xhol and ligated into pJM680 cut with the same 
enzymes. All of the clones were confirmed by DNA sequencing. 
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Point mutations within the GTPase domain and 3HB were generated by 
members of Andrea Daga's lab. To make the GST-tagged GTPase domain point 
mutants, atlastinKSlA (pJM694), atlastinR214C (pJM727), atlastinS234Y (pJM728), and 
atlastinR48A (pJM815), the mutant DNA sequences were digested using the unique 
restriction sites PpuMI and Sphl within the Drosophila atlastin sequence. The 
restriction fragments were ligated into pJM681 cut with the same enzymes. Soluble 
domain mutants were made by using the same enzymes and ligating the K51A and 
R48A point mutations into pJM704 to create pJM746 and pJM835, respectively. 
Similarly, the 3HB point mutations atlastinL400A (pJM702), atlastinF404P 
(pJM703), and atlastinlxlinker (pJM724), were digested with the unique restriction 
enzymes PpuMI and Sacl and ligated into pJM681 cut with the same enzymes. 
Atlastin(l-422) was moved to pGEX-ST by cutting pJM704 with the 
restriction enzymes BamHI and Eagl and ligating the DNA fragment into pGEX-ST 
cut with the same enzymes to create pJM781. Cutting with Eagl carried the C-
terminal acta-histidine tag with the sequence. 
2.1.3. Mutagenesis 
Two point mutations within the c-terminal cytoplasmic domain, 
atlastinF478K (pJM863) and atlastinL482K (pJM882), were generated by overlap 
extension PCR31. The outside oligos #583 and #590 were used for both. The 
phenylalanine-478 to lysine mutation was introduced using the overlapping oligos 
#767 (5'-GGA GAG CTC AGC GAC AAA GGC GGC AAG TTG GAT G-3') and #768 (5'-
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CAT CCA ACT TGC CGC CTT TGT CGC TGA GCT CTC C-3'). The leucine-482 to lysine 
mutation was introduce using the overlapping oligos #790 (5' -CGA CTT TGG CGG 
CAA GAA GGA TGA CTT TGC AAC-3') and #791 (5' -GTT GCA AAG TCA TCC TTC TTG 
CCG CCA AAG TCG-3'). The PCR products were cut with Sphl and Xhol and ligated 
into pJM681 cut with the same enzymes. 
Overlap extension PCR was also used to introduce a unique BspEI restriction 
site at residues serine-4 72 and glycine -4 73 of atlastin (pJM865) which are at the 
start of the c-terminal cytoplasmic domain. To do this the silent mutations 1413A>T 
and 1414G>C were made using the overlapping oligos #765 (5'-GCC TAC ATT AGA 
TAT TCC GGA GAG CTC AGC G-3') and #766 (5'-CGC TGA GCT CTC CGG AAT ATC 
TAA TGT AGG C-3') and the flanking oligos #583 and #590. The PCR product was 
cut with Sphl and Xhol and ligated into pJM681 cut with the same enzymes. 
The c-terminal cytoplasmic domain of drosophila atlastin (residues 473 to 
541) was swapped with the c-terminal cytoplasmic domain of human atlastin-1 
(pJM866, residues 499 to 558) and atlastin-3 (pJM868, residues 526 to 579). The 
corresponding DNA sequence from atlastin-1 was amplified using the oligos #771 
(5'-ATT CCG GAG AAT ACC GAG AGC TGG-3') and #777 (5'-ATC TCG AGC ATT TTT 
TTC TTT TCT GAT TGT TCA G-3'). The atlastin-2 DNA sequence was amplified with 
the oligos #773 (5'-ATT CCG GAC AAT ATC GTG AGC TGG GC-3') and #635 (5'- TTC 
TCG AGT TGA GCT TTT TTA TCC ATG G -3'). The PCR products were cut with BspEI 
and Xhol and ligated into p JM865 cut with the same enzymes. 
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2.2. Protein expression and purification 
A biochemical characterization of atlastin requires the isolation of purified 
protein. All recombinant protein was expressed in and purified from Echerichia coli 
BL21 (DE3) cells (Stratagene). The expression vectors used confer ampicillin (Amp) 
resistance to the cells. Cells were culture in lysogeny broth (LB)32 and on LB-agar 
plates that contained 100 11g per ml Amp. 
2.2.1. GST-tagged protein purification 
GST-tagged proteins were produced starting by transforming E. coli 
BL21(DE3) (Stratagene) cells with the respective expression plasmid. Overnight 
colonies were picked to start pre-precultures in S ml LB +Amp. The pre-
precultures were used to start SO ml precultures that were grown overnight at 2S°C. 
The cells from the SO ml precultures were pelleted at 3,000 rpm (-2,000xg) for 1S 
min using an Allegra tabletop centrifuge at room temperature. The cell pellet was 
used to seed 2 to 4 L cultures with a starting density of about 0.1 to 0.2 optical 
density at 600 nm (OD). The cultures were grown at 2S°C up to a desirable density 
(OD = 0.4 to O.S) at which time the culture was moved to a 16°C incubator. Ten 
minutes after growth at 16°C, the protein expression was induced with 0.2 mM 
isopropyl-~-D-1-thiogalactopyranoside (IPTG) and the cultures were grown 
overnight ( -16 hours) at 16°C. The cells were harvested, washed with 2S mM 
HEPES (pH 7.4) and 200 mM KCl and lysed in breaking buffer (25 mM HEPES (pH 
7.4), 200 mM KCl, 10% glycerol, 2 mM 2-mercaptoethanol (~ME), 4% Triton X-100, 
2mM EDTA and 1X complete protease inhibitor cocktail (Roche)) by passage 
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through an Emulsiflex C-3 high pressure homogenizer (Avestin) twice at 15,000-
20,000 psi. Cell extracts were cleared by centrifugation at 125,000 x ( -186,000xg) 
for 30 min using a Type 45-Ti rotor in an Optima LE-80K ultracentrifuge (Beckman) 
cooled to 4°C. Cleared extracts were incubated with 70 mg of swelled glutathione 
(GSH)-agarose beads (Sigma) for 1 hr at 4°C. 
GST-tagged proteins that have at least one transmembrane domain (pJM681, 
-694,-702,-703,-705,-706,-724,-727,-728,-813,-815,-863,-866,-868, and -882) 
were purified as follows. The GSH bead-bound protein was washed with 25 mM 
HEPES (pH 7.4), 100 mM KCl, 10% glycerol, 2 mM (3ME, 1% Triton X-100, and 1 mM 
EDTA. The protein was washed 5 more times with 10 ml of 25 mM HEPES (pH 7.4), 
100 mM KCl, 10% glycerol, 2mM (3ME, 0.1% ana poe X-100, and 1mM EDT A. The 
protein was eluted from GSH-agarose with 25 mM HEPES (pH 7.4), 100 mM KCl, 
10% glycerol, 2 mM (3ME, 0.1% anapoe X-100, 1 mM EDTA, and 10 mM GSH. 
Identical conditions were used for the soluble fragments of atlastin (pJM704, -7 46, 
and -835) with the exception that detergent was left out of the wash and elution 
buffers. 
The proteins were analyzed by SDS-PAGE and coomassie stain and the 
protein concentration was determined by amido black protein assay33• Frozen 
aliquots were stored at -80°C. 
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2.2.2. GST-SUMO-tagged protein purification 
For GST-SUMO-tagged proteins (pJM781 and pJM841) the cell growth and 
protein expression was the same as for the GST -tagged proteins. The washed cells 
were lysed in 20 mM Tris pH 7.5, 200 mM KCl, 10% glycerol, 2 mM ~ME, 2 mM 
EDT A, 1X complete protease inhibitor cocktail (Roche) and 4% Triton X-100. The 
lysate was cleared by centrifugation at 125,000xg for 1 hr at 4°C. The cleared lysate 
was added to 2 ml of equilibrated GSH-agarose beads and incubated for 3 hours at 
4°C. The beads were pelleted and unbound protein was removed by aspiration. The 
beads were added to a 10 ml polyprep column (BioRad) and washed twice with 10 
ml ofTris wash buffer (20 mM Tris pH7.5, 200 mM KCl, 5% glycerol, 0.5 mM TCEP, 
and 0.5% Triton X-100). The washed beads were resuspended in 10 ml Tris wash 
buffer and the protein was cleaved off of the beads with 0.1 mg GST-SENP2365-SB9 
protease overnight at 4°C. The cleaved protein was eluted out of the column into a 
15 ml falcon tube by centrifugation then diluted with 20 mM Tris pH 7.5 so that the 
concentration of KCl was below 40 mM. The diluted protein was passed over a Q-
sepharose column (0.5 ml/min), the detergent was washed away, and the protein 
was eluted off the column with a salt gradient from 40 mM to 1 M KCI. Peak 
fractions were pooled and desalted over two 5 ml Sephadex G-25 columns 
equilibrated in 20 mM Tris pH7.5, 200 mM KCl, 5% glycerol and 0.5 mM TCEP. The 
purified protein was aliquoted, plunged in LNz, and stored at -80°C 
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2.2.3. SENP2 protease purification 
In order to cleave the SUMO-tag off of the GST-SUMO-tagged proteins we 
purified recombinant, GST-tagged SENP2 protease. A pGEX vector containing the 
sequence for residues 365-589 ofSENP2 protease was transformed into BL21(DE3) 
cells (Stratagene). Cells were grown in SuperBroth (Takara)+ 100 ~g/ml Amp in a 
37°C incubator. A 250 ml overnight preculture was used to seed 4liters of 
SuperBroth +Amp at an initial OD of 0.3 to 0.4. When the cells reached an OD 
between 0. 7 and 0.8, protein expression was induced with 0.5 mM IPTG for 4 hours 
at 37°C. After 4 hours of expression the cells were harvested by centrifugation and 
washed once with 25 mM HEPES (pH7.4) and 200 mM KCI. The cells were broken in 
25 mM HEPES (pH 7.4), 200 mM KCl, 10% glycerol, and 2 mM ~ME and the extract 
was centrifuged for 1 hour at 125,000 x gat 4°C. The cleared extract was incubated 
with 70 mg of swelled GSH-agarose beads (Sigma) for 1 hr at 4 °C. The protein on 
the GSH-beads was washed with 20 ml of 25 mM HEPES (pH 7.4), 100 mM KCI, 10% 
glycerol, and 2 mM ~ME. The protein was eluted from the GSH-agarose beads with 
25 mM HEPES (pH 7.4), 100 mM KCl, 10% glycerol, 2 mM ~ME, and 10 mM reduced 
GSH. The purified protein was diluted with HE PES buffer without salt so that the 
concentration of KCl was below 40 mM and then passed over a SP-sepharose 
column (GE). Protein was eluted off of the column using a salt gradient from 40 mM 
to 1 M KCI. Peak fractions were pooled and stored in 50% glycerol at -20°C. The 
protein concentration was determined by the Bradford protein assay34• 
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2.3. Production of atlastin proteoliposomes 
Purified recombinant GST- atlastin was reconstituted into synthetic 
liposomes to test for fusion. 
2.3.1.1. Liposome preparation 
Liposomes were made by the extrusion method as follows3s. Unlabeled lipid 
mixes (POPC:DOPS, 85:15 mole ratio) and labeled lipid mixes 
(POPC:DOPS:Rhodamine-DPPE: 7-nitro-2,1,3-benzoxadiazol (NBD)-DPPE, 
83:15:1.5:1.5 mole ratio) in chloroform were dried under a stream ofNz gas 
followed by further drying in a vacuum for 30 min. The lipid films were then 
resuspended in A100 buffer (25 mM HEPES pH 7.4, 100 mM KCl, 10% glycerol, 2 
mM BME, 1 mM EDTA) to a final total lipid concentration of about 10 mM. Large 
unilamelar vesicles (LUVs) were formed by 10 repeated freeze-thaw cycles in liquid 
N2 and room temperature water. Liposomes were formed by extruding the LUVs 
trough polycarbonate filters with 100 nm pore size (Avanti Polar Lipids). All the 
lipid mixes include trace amounts of3H-lipid to determine the lipid concentrations 
ofliposomes by liquid scintillation counting. 
2.3.1.2. Atlastin reconstitution 
GST-atlastin in 0.1% Triton X-100 (or 0.1% anapoe X-100) was reconstituted 
into both labeled and unlabeled 100 nm liposomes by the detergent assisted 
insertion method 35. The protein in detergent was mixed with preformed liposomes 
at an effective detergent to lipid of about 1. The effective detergent to lipid ratio 
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(Reff) was determined by the following equation: 
Dwater 
Ref[ = Dtotal - [lipid] 
Equation 2-1: Detergent saturation ofliposomes 
where Dtotal is the total detergent concentration and Dwater is the monomeric 
detergent concentration (0.18 mM) in the presence of detergent36. The protein and 
lipid were mixed for 1 hour at 4°C. Detergent was removed by BioBeads® SM-2 
adsorbant (BioRad) overnight at 4°C. Insoluble protein aggregates were pelleted by 
at 16,000xg for 10 min in a microcentrifuge cooled to 4°C. Final lipid and protein 
concentrations were determined by liquid scintillation counting and amido black 
protein assay33, respectively. The liposomes sizes were confirmed by dynamic light 
scattering (DLS). 
2.4. Measuring membrane fusion in vitro 
2.4.1./n vitro fusion assay 
Fusion assays were based upon the previously described37 method used for 
analyzing SNARE-mediate fusion in vitro with the following modifications. Labeled 
and unlabeled populations of atlastin proteoliposomes (0.3 mM lipid each) were 
mixed in the presence of 0.5 to 1 mM GTP and brought to total volume of 45 111 with 
A100 buffer in well of96-well Fluoronunc polysorp plate (Nunc). The samples in 
the plate were incubated at 37°C in fluorescent plate reader (Infinite m200, TECAN) 
for 5 min. To each well 5 111 of 50 mM Mg2+ was added and NBD fluorescence was 
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Figure 2-1: In vitro fusion assay 
Cartoon depictions of a standard in vitro fus ion assay (a) and inner-leaflet mixing assay 
(b). (c) Excitation and emission spectra of the FRET pair NBD and Rhodamine 
(SpecraViewer, Invitrogen). See text for details. 
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measured (excitation 460 nm, emission 538 nm, Figure2-1) at 1 min 
intervals for 60 min with 1 s shaking after every read. To determine the absolute 
NBD fluorescence 10 Ill of 2.5% (w fv) n-dodecylmaltoside was added at 60 min. 
Data was normalized to percent total fluorescence. 
The fusion measurement depends upon head-group labeled lipids in the 
labeled population of liposomes. The NBD and rhodamine labeled lipids are at a 
concentration (1.5 mole% of each) where the fluorescence of NBD is quenched by 
the rhodamine (Figure 2-1c). Under fusion conditions when liposomes fuse and mix 
their lipids the fusion oflabeled liposomes with unlabeled liposomes dilutes the 
concentration of the labeled lipids 2-fold resulting in a relief of FRET and increase in 
NBD fluorescence (Figure 2-1a). We measure an increase in NBD fluorescence over 
time as a representation of membrane fusion. 
The data are normalize to the maximum fluorescence after addition of 
detergent and are represented as a plot of percent of maximum fluorescence 
intensity(% of maximum) over time. 
2.4.2. Inner-leaflet mixing 
Inner-leaflet mixing (Figure 2-1b) is measured by reducing NBD to the non-
fluorescent 7-amino-2,1,3-benzoxadiazol (ABD) with a membrane impermeable 
compound, dithionite (DTH). Labeled proteoliposomes are mixed in a 96 well 
fluoronunc polysorp plate and warmed to 37°C in TECAN Infinite M200 
fluorescence plate reader. 100 mM dithionite in buffer (25 mM HEPES-KOH pH10, 
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10% Glycerol100 mM KCl) is added to the wells before the initiation of fusion with 
Mg2+. After addition of DTH does not result in further reduction in NBD signal the 
fusion reaction is performed the same as for the standard in vitro fusion assay. The 
NBD fluorescence is measured at 1 minute intervals and detergent (2.5% 
dodecylmaltoside) is added after 60 minutes to determine maximum fluorescence. 
2.4.3. Dynamic light scattering 
All the DLS data were acquired using Malvern Zetasizer Nano ZS and 
ZEN0040 cuvette. The scattering of light was recorded at 173°C (back scattering). 
The light intensity and the measurement time were automatically set by the 
software. To measure the dynamic change of liposome size, the experiments were 
performed at 37°C with 150 !J.M liposome in A100 buffer (100mM KCl, 25mM 
HEPES, 10% Glycerol, 1mM EDTA). Different nucleotides, Mg2+ or EDTA were 
added between measurements. The data are represented as Z-average size 
(diameter, nm). 
2.4.4. Negative-stain transmission electron microscopy 
Atlastin proteoliposomes (1 mM total lipid) were incubated with or without 
2 mM GTP and 5 mM Mg2+ for 15 min at 37°C. EDTA was added to 10 mM 
concentration to stop liposome fusion following incubation. Samples were absorbed 
to bacitracin-treated carbonjformvar coated copper grids (Ted Pella), incubated for 
3-5 min at room temp, and washed with 0.45 !J.M filtered 1% (w fv) ammonium 
molybdate. Samples were stained with 1% (w fv) ammonium molybdate for one 
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minute at room temperature and dried for at least 30 min. Stained samples were 
imaged on a JOEL 1230 high contrast transmission electron microscope operated at 
80 keV. 
2.5. GTPase activity measurements 
2.5.1. Reversed-phase ion-paired high-performance liquid 
chromatography 
Nucleotide species produced by atlastin were analyzed by reversed-phase 
ion-paired HPLC. GTPase reactions were setup by adding 0.5 mM GTP to 5 11M 
atlastin(1-422) brought up to a 350 111 volume with buffer A100. The reaction 
mixture was warmed to 37°C, 40 !J.l were removed for the 0 time point, and 5 mM 
MgClz was added to start the reaction. For every time interval 40 111 were removed 
and added to a 0.5 ml microcentrifuge tube on wet ice containing 2.5 111 of 10% 
perchloric acid to precipitate the protein and stop the reaction. Following a 2 min 
incubation on ice the pH was raised by the addition of 1.75 111 of 4 M sodium acetate 
pH 4.0 and the precipitated protein was removed by centrifugation at 16,000xg for 5 
minutes at 4°C. A Zorbax Eclipse XBD C-8 HPLC column (agilent) was equilibrated 
with running buffer comprised of 50 mM sodium phosphate pH 7, 10 mM tetra-n-
butylammonium bromide (TBAB), and 7% acetonitrile. The nucleotide products 
were measured by running 20 111 of the cleared samples over the equilibrated 
column and measuring the absorbance at 254 nm. GTP, GDP, and GMP in buffer 
A100 were run over column as standards. 
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2.5.2. EnzChek® phosphate assay 
GTPase activity measurements were done using an EnzChek® Phosphate 
assay kit (Invitrogen). A standard protocol for GTPase measurments involved 
mixing recombinant atlastin and atlastin mutants in a 150 jJ.l reaction volume with 1 
Ufml purine nucleoside phosphorylase (PNP), 200 IJ.M 2-amino-6-mercapto-7-
methyl purine riboside (MESG) and GTP in a transparent 96-well half-area plate. 
The plates were warmed to 37°C in a microplate reader (Tecan, Infinite M200) and 
5 mM Mg2+ was added to start the reaction. In the presence of inorganic phosphate, 
PNP catalyzes the conversion ofMESG to ribose 1-phosphate and 2-amino-6-
mercapto-7-methylpurine resulting in a spectrophotometric shift in absorbance 
from 330 nm to 360 nm (Figure2-2). The absorbance increase at 360 nm was 
measured in real-time every 30 seconds over 20 minutes. 
GTPase assay data were analyzed by determining the initial rates of 
phosphate release as measured by the increase in absorbance at 360 nm and 
normalizing the data to a phosphate standard. For GTPase activity measured over a 
0 
P; PNP > 
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+ ~-c~--1--o 
OH OH 
Absmax = 330 nm 
Figure 2-2: EnzChek® Phosphate Assay 
A spectrophotometric shift from 330 nm to 360 nm during the conversion of MESG to 2-amino-6-
mercapto-7 -methyl-purine and ribose-1-phosphate by the enzyme PNP is used to measure inorganic 
phosphate produced in a GTPase reaction. 
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range of GTP concentrations the data was fit by the Michaelis-Men ten equation to 
derive enzyme parameters. 
v= 
Vmax * [GTP] 
Km + [GTP] 
Equation 2-2: Michaelis-Menten equation 
2.6. Fluorescent nucleotide binding experiments 
Equilibrium binding was done by measuring the change in fluorescence ofN-
methylanthraniloyl (mant)-nucleotides upon binding to soluble atlastin. In a black 96-
well plate 1 ~M mant-GTPyS or 1 ~M mant-GDP was added to increasing amounts of 
purified GST-atlastin (1-422), GST-atlastin(1-422)K51A, or GST-atlastin(1-422)R48E. 
The mant fluorescence (A.Ex=366 nm, A.Em=435 nm) was measured in a TECAN infinite 
M200 fluorimeter every 2 minutes for 20 minutes and averaged. The absolute fluorescent 
intensities were plotted versus protein concentration and curve fitted to determine the 
equilibrium dissociation constants(~) according to the following equationuation38 : 
Equation 2-3: Curve fiting equation for nucleotide equilibrium binding. 
where Fmin is the fluorescence minimum, Fmax is the fluorescence maximum, Ao is the 
concentration ofprotein in J..LM, Bois the concentration ofmant-GTPyS in 11M and Kd 
is the equilibrium binding constant in J..LM. A global value of Fmax from was used in all 
three curve fits. Measurements were carried out with at least two independent 
preparations of each protein. 
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2. 7. Analytical ultracentrifugation 
Analytical ultracentrifugation experiments were performed using a Beckman 
Optima XLA analytical ultracentrifuge. Buffers used were 20 mM Tris pH 7.5, 200 
mM KCI, 0.5 mM TCEP, 5%(w/v) glycerol. Sedimentation velocity experiments were 
carried out with 3.5 11M protein and 20 11M nucleotide in cells assembled with 12 
mm, 2-channel aluminum centerpieces. Water was used in the reference channel of 
each cell. Experiments were carried out at 50,000 or 55,000 rpm in an AN60 rotor 
at 20°C. Intensity at 235 nm versus radial position was measured at 4 min intervals 
for 4 to 5 hours. All data analysis was done using Ultrascan 1139. The intensity data 
were converted to pseudo-absorbance using water as the reference channel. Time-
invariant and radial-invariant noise was fit to the data by two-dimensional spectral 
analysis (2DSA) and subtracted from each data set. The edited data were analyzed 
using the enhanced van Holde-Weischet module in Ultrascan to determine diffusion-
corrected Sw,zo values for each samples. The data were further analyzed to 
determine frictional ratios and molecular weights by fitting the data to a model by 
least squares methods using parameters describing the sedimentation and diffusion 
of the samples. 
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Chapter 3 
Drosophila Atlastin Mediates 
Membrane Fusion 
3.1. In vivo evidence that atlastin is involved in endoplasmic 
reticulum membrane fusion 
Our collaborator Andrea Daga (E. Medea Scientific Institute, Italy) initially 
suggested to the MeN ew lab that atlas tin may be directly responsible in ER 
membrane fusion. Work performed in their lab using the model organism 
Drosophila melanogaster supported their hypothesis that atlastin plays a direct role 
in ER fusion. They found that atlastin, an integral membrane GTPase, is localized to 
the ERin flies without any colocalization with golgi markers4o. Atlastin was shown 
to form a homooligomer in immunoprecipiation assays4o. And as shown below 
misexpression of atlastin results in abnormal ER morphologies. 
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3.1.1. Depletion ofatlastin results in ER fragmentation 
To gain insight into the function of atlastin, the consequences of 
down regulating the expression of atlastin in Drosophila by in vivo RNAi was 
examined. The Daga lab generated UAS-atlastin-RNAi transgenic flies, whose 
expression could be controlled using the Gal4/UAS system41. Loss of atlastin in 
muscle and neurons resulted in severely undersized and fragmented ER profiles in 
contrast to control neuron ER profiles (Fig. 3-1)40. EM analysis showed analogous 
shortened, fragmented ER profiles in atll null mutant neurons7 (Fig. 3-1). These 
results indicate that the ER is fragmented in direct response to a loss of ER 
membrane fusion and atlastin plays a close role in this process. 
The functional consequences of these morphological changes in ER structure 
were examined by fluorescence loss in photo bleaching (FLIP) experiments. Loss of 
a fluorescent marker from a region of a cell upon repeated photo bleaching of a 
different region indicates continuity between the two regions. FLIP experiments 
targeting GFP-KDEL42•43 were used to assess whether fragmentation in atlastin-RNAi 
tissue resulted in discontinuity of normally interconnected ER elements. Unlike in 
control muscle where loss ofGFP-KDEL fluorescence was homogeneous, repetitive 
photobleaching of GFP-KDEL in tubulin-Gal4/+; UAS-atlastin-RNAi/+ muscles 
produced regions of unbleached fluorescence (Fig. 3-1)40, indicating that in these 
areas the ER network lacked its typical continuity. These data reinforced the EM 
observations demonstrating that removal of atlastin results in ER fragmentation. 
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a Control Dati RNAi atN atfl 
Figure 3-1: Atlastin depletion in flies results in shortened, fragmented ER 
(a)TEM images of motor neurons show normal tubular ER(arrowheads) in WT flies and fragmented 
ER (arrows) in atlastin RNAi and atlastin null flies (Scale bar, 0.5 11m; G, golgi; n, nucleus; pm, plasma 
membrane) (b)FLIP experiments on fly muscle cells expressing GFP-KDEL that were repeatedly 
photo bleached (white outlines) while fluorescence intensity was measured in adjacent regions 
(colored outlines, scale bar, 20 11m). (c) Kinetic graphs of FLIP experiments. Experiments performed 
in the lab of Andrea Daga. 
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3.1.2. Overexpression of atlastin results in ER expansion 
Since reduction in atlastin levels produced ER fragmentation, a 042-
Gal4/+;UAS-atlastin-mycj+ fly line overexpressing atlastin in the brain was 
Figure 3-2: Transmission electron micrographs 
reveal cells overexpressing atlastin have 
expanded, dilated ER. 
TEM analysis of D42-Gal4/+;UAS-atlastin-myc/+ 
motor neurons show that overexpressing Atlastin 
exhibit results in an expanded ER(asterisks) and 
nuclear envelope (white arrows). Note a non-
overexpressing neuron with normal tubular ER 
morphology (black arrowheads). Scale bar, 0.5 mm. 
m, mitochondrion; n, nucleus; pm, plasma 
membrane. Black arrows denote ribosomes. 
Experiments performed in the Daga lab. 
constructed to determine whether 
atlastin was directly involved in 
fusion and would result in excessive 
ER fusion. EM analysis of 042-
Gal4 I+; UAS-atlastin-mycj + brains 
revealed that atlastin overexpression 
results in an abnormal ER 
morphology. Normal tubular ER 
profiles were absent in atlastin 
overexpressing motorneurons where 
ER membranes formed expanded 
cisternae (Fig. 3-2)40. This expansion 
of ER elements is consistent with an 
increase in membrane fusion and 
suggested that atlastin itself could 
directly mediate bilayer merger. 
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3.2. In vitro measurements of atlastin mediated fusion 
The in vivo experiments performed by our collaborators suggested that 
atlastin may play a direct role in ER membrane fusion. To determine whether this is 
true we made purified recombinant GST -tagged Drosophila atlastin from E. coli 
(BL21) cells. The recombinant protein was purified over a glutathione (GSH)-
column and eluted off the column with free glutathione. Since atlastin is a 
membrane protein it has to be purified in detergent. Initial attempts to purify 
atlastin in mild octyl-glucoside detergents resulted in precipitation of the protein. 
We instead purified the protein in low amounts of Triton X-100. To test the fusion 
activity of purified recombinant atlastin we needed to reconstitute the protein into 
the lipid bilayer of synthetic liposomes. The need to purify atlastin in Triton X-100 
made it difficult to reconstitute the protein into liposomes by traditional dilution-
dialysis methods37 and necessitated the use of a different method of protein 
reconstitution. 
Atlastin was reconstituted into preformed 100 nm liposomes by detergent-
assisted insertion44 followed by detergent removal with BioBeads absorbant SM-2. 
The resultant atlastin proteoliposomes were assayed for fusogenic activity using 
three techniques. 
3.2.1. Atlastin promotes lipid mixing 
First, an in vitro fusion assay made standard in studies of SNARE proteins37 
was used to assess whether atlastin could promote membrane fusion. Recombinant 
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Figure 3-3: Atlastin proteoliposomes undergo fusion in the presence ofGTP and Mg2 +, 
(Left)GST-atlastin drives fusion in vitro. Kinetic fusion graph of unlabeled fly atlastin 
proteoliposomes fused with equimolar fluorescently labeled fly atlastin proteoliposomes. NBD 
fluorescence was measured at 1 minute intervals and 2.5% dodecylmaltoside was added at 60 
minutes to determine maximum fluorescence. Fusion is represented as a percent of maximum 
fluorescence intensity(% of maximum) over time. The extent of fusion at 60 minutes is shown as a 
histogram inset. (Middle) Surface density concentration dependence of fly atlastin-mediated fusion. 
Surface density is represented as a protein: lipid molar ratio. (Right) Coomassie-stained gel of 
proteoliposomes analyzed in middle panel run on SDS-PAGE gel. Data by Song Liu (McNew Lab) 
GST -atlastin was reconstituted into two populations of preformed liposomes44 . 
Acceptor proteoliposomes containing unlabeled lipids and donor proteoliposomes 
contained these lipids as well as equimolar amounts of NBD and rhodamine head-
group labeled lipids. NBD and rhodamine form a FRET pair and fusion is measured 
as an increase in NBD fluorescence (Figure2-1) over time as lipid mixing between 
donor and acceptor proteoliposomes dilutes the fluorescence probes in the newly 
merged membrane. Lipid-mixing assays were carried out by mixing equimolar 
donor and acceptor proteoliposomes and then adding GTP and Mg2+ to trigger 
fusion (Fig. 3-3). GST -Atlastin proteoliposomes in the presence of Mg2+ and GTP 
drives robust fusion that is completely dependent on GTPase activity (see chapter 
4). The fusion observed is dependent upon concentration of protein in the 
liposomes (Figure3-3). 
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3.2.2. Atlastin promotes inner-leaflet mixing 
The in vitro fusion assay measures total lipid mixing and does not 
discriminate between full fusion and outer-leaflet mixing. The possibility remained 
that the lipid mixing observed was due only to aggregation of liposomes and 
merging of the outer leaflets alone. To test if full fusion occurs between atlastin 
proteoliposomes I measured the extent of inner-leaflet mixing. This is done by 
preferentially quenching the NBD in the outer-leaflet of the atlastin proteoliposomes 
with the membrane impermeable reducing agent dithionite (DTH) (Figure 2-1). 
Labeled atlastin proteoliposomes treated with DTH show about a 3-fold decrease in 
NBD signal (Figure 3-4). After Mg2+ and GTP addition to the DTH-treated atlastin 
proteoliposomes lipid mixing still occured as represented in an increase in NBD 
fluorescence (Figure 3-4). This suggests that atlastin promotes full fusion. 
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Figure 3-4: Atlastin promotes the full fusion ofliposomes. 
Labeled atlastin proteoliposomes are treated with 100 mM dithionite (DTH) 13.5 and 8.5 minutes 
before the initiation of fusion with GTP and Mg2+. The relative fluorescence decreases (left) as the 
NBD in the outer-leaflet of the liposomes is quenched with DTH. NED-labeled headgroups protected 
from DTH in the inner-leaflet of the liposomes show increased fluorescence (right) as the liposomes 
fuse. 
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3.2.3. Atlastin promotes aggregation of liposomes 
A second indirect method of measuring fusion was used to support the lipid 
E' 
-S 
200 -
Q) 180 
N 
i:i5 
Q) 
0> 
ro Q) 160 
> ro 
I 
N 
140 
GTP+Mg2' 
- --- GTPyS+Mg2• 
12o ~~~~~~~~~~~~~~ 
mixing results as this was the first time 
that a Dynamin-like GTPase was shown 
to be involved in membrane fusion. The 
hydrodynamic diameter of atlastin 
proteoliposomes was analyzed by 
dynamic-light scattering (DLS). The 
average diameter of atlastin 
0 5 10 15 20 25 30 35 proteoliposomes was about 125 nm and 
Time (min) 
Figure 3-5: Atlastin proteoliposome size 
measurements 
the diameter increased after the addition 
DLS size measurements taken over 3 minute of GTP and Mg2+ consistent with a role 
intervals. Atlastin proteoliposome size increases 
after the addition of GTP and Mg2+, but not GTPyS. 
Data by song Liu. for atlastin in membrane fusion. The 
average diameter of the liposomes increased until the GTPase activity was quenched 
by the sequestering of free Mg2+ with the addition of the metal chelating compound 
EDTA (Figure 3-5). After the GTPase activity was quenched the size of the atlastin 
proteoliposomes decreased to an average diameter of about 165nm (Figure 3-5). 
These data suggest that under these conditions there may be some aggregation of 
GST-atlastin proteoliposomes that may or may not lead directly to fusion. The 
aggregates were broken apart by the addition of EDT A and the average size settled 
at an average diameter consistent with a doubling in the surface area of the 
liposomes. DLS measurements support the lipid mixing assay and suggest that GST-
atlastin proteoliposomes undergo on average of one round of fusion. 
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3.2.4. Atlastin promotes an increase in liposomes diameter 
Lastly, a more direct method of analyzing liposome fusion is to image the 
liposomes by microscopy. The diameter of the liposomes is roughly 100 nm which 
is below the resolution of light microscopy. Thus, I imaged the atlastin 
proteoliposomes by electron microscopy. Atlastin proteoliposomes were incubated 
in buffer or with 5 Mg2+ and 2 mM GTP for 15 min at 37°C. Fusion was stopped by 
the addition of 10 mM EDTA following incubation. The liposomes were absorbed to 
bacitracin-treated grids and negative-stained with ammonium molybdate. The 
liposomes are modestly deformed by the negative-staining protocol; however it is 
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Figure 3-6: Transmission electron microscopy of negative-stained atlastin 
proteoliposomes. 
(a) Unfused atlastin proteoliposomes incubated without GTP. 12,000x magnification. (b 
and c) Fused atlastin proteoliposomes incubated with 2 mM GTP. 10,000x magnification. 
(d) The atlastin proteoliposomes treated with GTP prior to imaging showed a greater 
average diameter ( ~122 nm) relative to the untreated proteoliposomes ( ~79 nm). Scale 
bars, 200 nm. 
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clear the liposomes have an increased diameter in the samples with GTP (Figure 3-
6). 
Of note is that the liposomes are spherical (Figure 3-6) after GTP addition, 
the same conditions where lipid mixing is observed. This is a clear distinction from 
dynamin which form tubules out ofliposomes in the presence of GTP45. Atlastin is a 
distant member of the dynamin superfamily of GTPases. 
3.3. Conclusions 
These in vitro results coupled with the in vivo evidence from our 
collaborators convinced us that atlastin is able to fuse membranes and is directly 
responsible for the fusion of ER membranes. 
Concurrent with the publication of our results an article14 from the lab of 
Tom Rapoport (Harvard Medical School) came to the same conclusion, i.e. that 
atlastin is the GTPase responsible for ER membrane fusion. They showed that HeLa 
cells that are atlastin depleted have long unbranched ER tubules. Additionally, they 
used an assay that they had previously established12 wherein they are able to 
reform ER networks from microsomes extracted from Xenopus eggs. This in vitro 
ER network formation is inhibited by a pan-atlastin antibody14. 
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Chapter 4 
Atlastin oligomerization 
4.1. Atlastin forms homooligomers in vivo 
Atlastin is responsible for the homotypic fusion of ER membranes. 
Homotypic fusion is the fusion of two membranes that are indistinguishable from 
each in their protein and lipid content. Atlastin must be present in both bilayers to 
promote fusion (data not shown) ergo, atlastin must self-associate to form homo-
oligomers prerequisite to promoting fusion. 
Most large GTPases, like atlastin, form higher order oligomeric structures 
and human Atlastin-l(Atll) has been shown to self-associate in vivo. In vitro 
analysis of theN-terminal cytoplasmic domain of Atl146 revealed that it is a 
monomer that shifts to a size consistent with a dimer in the presence of 
nonhydrolyzable GTP46. However, immunoprecipitated full-length Atll migrates as 
an apparent homotetramer by gel filtration23, as does Atl2 and Atl3 26. Either the 
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transmembrane segments and the C-terminal tail influence oligomerization, or the 
immunoprecipitated material from detergent extracts contained additional mass 
not attributable to atlastin. Attempts to identifY heteroligomeric complexes have 
met with mixed results. Endogenous Atll and Atl2 do not coprecipitate other 
atlastins; however, mixed heteroligomeric complexes can be coprecipitated when 
atlastins are overexpressed26. 
In vivo data from the Daga Lab confirms that Drosophila atlastin is also 
capable ofhomooligomerization. They performed co-immunoprecipitation of 
atlastin-myc and atlastin-HA coexpressed in HeLa cells and demonstrated the self-
association of atlastin molecules40. Additionally, they prepared microsomes from 
HeLa cells separately transfected with atlastin-myc or atlastin-HA. When anti-myc 
antibodies were used to precipitate atlastin-myc harboring vesicles, atlastin-HA was 
recovered in the pellet. Fractionation of cleared cell homogenates showed that 
atlastin and the ER resident integral membrane protein calnexin partitioned 
exclusively to the membrane fraction while the ER-lumenal protein PDI remained in 
the soluble fraction. These experiments demonstrated that under these lysis 
conditions atlastin associated with membranes and atlastin binding occurred 
between distinct vesicles4o. 
4.2. Atlastin dimerization 
In vivo methods show oligomerization of atlastin but do not clearly show the 
number of subunits in the atlastin homooligomer. I purified two soluble forms of 
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atlastin, atlastin(l-422) and atlastin (1-328), to be able to work with the 
recombinant protein in the absence of detergent so that I didn't get any contribution 
in size from detergent micelles. I expressed and purified fly atlastin(l-422) which is 
lacking the 2 TMDs and the c-terminal cytoplasmic domain. The GST -SUMO-tagged 
atlastin(l-422) was made by tandem purification over a GSH-column followed by 
ion-exchange. The GST-SUMO-tag was cleaved off by SENP2 protease prior to 
purification by ion exchange. 
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Figure 4-1: Sedimentation velocity analysis of atlastin (1-422) 
(A,D, and G) Edited data plots (black) and the best fit models (red) of sedimentation velocity 
experiments with atll-422 in the presence ofbuffer only, 20 1-!M GDP, or 20 1-!M GTPyS. Every 2nd and 
3rd radial scan is excluded for ease of viewing. Residuals (B, E, and H) and Pseudo-3D plots (C, F, and 
I) of the respective species best describing the fitted models show that atlastin(l-442) is monomeric 
in buffer and 20 11M GDP, 48.7 kDa and 45.3 kDa respectively. In the presence of 20 11M GTP atlastin 
(1-422) forms a homo-dimer, 86.3 kDa. 
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Figure 4-2: Sedimentation velocity analysis ofatlastin (1-328) 
A,D, and G) Edited data plots (black) and the best fit models (red) of sedimentation velocity 
experiments with atll-422 in the presence of buffer only, 20 !-LM GOP, or 20 !-LM GTPyS. Every 2nd and 
3rd radial scan is excluded for ease of viewing. Residuals (B, E, and H) and Pseudo-3D plots (C, F, and 
I) of the respective species best describing the fitted models show that atlastin(l-442) is monomeric 
in buffer, 20 11M GOP and, 20 11M GTP; 36.6 kDa, 43.0 kDa, and 41.0 kDa respectively. 
To address the question of oligomerization directly, we measured the 
molecular mass of atlastin (1-422) and atlastin (1-328) by analytical 
ultracentrifugation (AUC) 47. Figures 4-1 and 4-2 show the results of velocity 
sedimentation experiments for these proteins. The edited radial scans fitted with a 
genetic algorithm analysis using Ultrascan IJ39 to determine the sedimentation and 
frictional coefficients of protein migrating through the cells in buffer only, 20 J.lM 
GOP or J.lM GTPyS. When sedimentation and frictional coefficients were known, 
molecular weights were able to be calculated. Atlastin (1-422) showed molecular 
weights of 48.7 (Apo), 45.3 (GOP) and 86.3 (GTPyS) kOa respectively (Figure 4-1). 
The predicted monomer molecular weight of atl (1-422) is 49,317 Oa strongly 
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suggesting that both the apo and GOP-bound protein is monomeric while the GTPyS-
bound protein forms a dimer. A similar analysis with atl (1-328) produces a 
different result. In this case, all three species (apo, GOP and GTPyS) migrate at a size 
most consistent with a monomer molecular weight (36.6, 43.0, and 41.0 kOa, 
respectively). The predicted monomer molecular weight of atl (1-328) is 37,243 Oa. 
These data suggest that the middle domain 3HB of atlastin is important to form or 
stabilize dimers. 
Taken together, GTPase activity measurements and molecular weight 
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Figure 4-3: GTPase activity measurements of 
atlastin (1-422) and atlastin (1-328) 
(A) Michaelis-Menten kinetics of the atlastin 
soluble domains. Atlastin (1-422) Km = 9.3 11M 
and Vmax = 2.2 11M/min. The GTPase activity is 
almost completely eliminated in atlastin (1-328) 
when the middle domain is missing. Error bars, 
SEM. (B) Michaelis-Menten kinetics of atlastin 
(1-328) over a higher range ofGTP concentration 
with 1 to 5 11M enzyme. (C) Atlastin (1-422) 
titration (0.02-25 11M) 1 11M mant-GTPyS (open) 
or mant-GDP (filled). Equilibrium binding 
constants (Kd) were calculated as described in the 
methods: mant-GTPyS = 2.3 ± 0.2 11M, mant-GDP 
= 3.4 ± 0.4 11M 
analysis by analytical ultracentrifugation suggests that theN-terminal cytoplasmic 
domain of Drosophila atlastin can dimerize in the presence of GTP and that 
nucleotide binding promotes a conformation that requires the middle domain for 
stable oligomerization. 
GTPase activity measurements (Figure4-3) and soluble domain inhibitor results 
(see chapter 6) suggest that the ((middle domain" of atlastin may be important for 
oligomerization. Atlastin(1-328) does not form a dimer and shows weak enzymatic 
properties. Michaelis-Menten kinetics could not be fitted for atlastin (1-328) at 
these protein and GTP concentrations as opposed to atlastin (1-422) (Figure 4-3a). 
At higher concentrations of enzyme and GTP the soluble GTPase domain alone 
shows greater GTPase activity and can be weakly fit by the Michaelis-Menten 
equation (Figure 4-3b ). 
4.3. Conclusions 
Recently, two reports detailing the X-ray structure of theN-terminal 
Figure 4-4: Crystal structures of human atlastin 1 
Crystal structures of human atlastin-1 reveal to forms of atlastin when bound to 
nucleotide. Form 1 (3QSD) represents a post-fusion (cis) dimer. Form 2 (3QSE) represents a 
pre-fusion (trans) dimer. Green GTPase domain, orange linker, red 3-helix bundle. 
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cytoplasmic domain of human Atlastin-1 were published46,4B. These data provide 
important insights into both the biochemical properties and potential fusion 
mechanism of atlastin. The large GTPase domain shares significant structural 
similarity to human guanylate binding protein-1 (hGBP1)49 and the "middle 
domain" folds into an antiparallel 3-helix bundle (3HB) that would connect the 
GTPase domain to the tandem transmembrane segments. The GTPase domain is 
connected to the 3HB by a flexible linker. Both groups identified two crystal forms of 
Atlastin-1 (1-446) differing by the position of the 3HB relative to the GTPase 
domain. Crystal form 146 (Figure4-4) would likely position the transmembrane 
domains in a "post-fusion" conformation4B, while crystal form 2 probably represents 
a pre-fusion structure. All of the current structures contained bound GDP although 
attempts were made to bind nonhydrolyzable GTP analogs like GTPyS or GMPPNP. 
Biochemical analysis of the Atl1 (1-446) N-terminal cytoplasmic domain 
showed that GTPase activity of the wild type human protein was comparable to our 
Drosophila protein (5.33 ~M Pi/ min I ~M enzyme for Atll (1-446) vs. 4.4 for ~M Pi/ 
min I ~M enzyme for atl (1-422)) and that GTP promoted dimerization measured by 
small angle X-ray scattering (SAXS)46 or analytical ultracentrifugation (AUC)48. 
Additionally, both groups measured dimerization by gel filtration in the presence of 
GDP that yielded different outcomes. Tom Rapoport's group4B identified atlastin 
dimers in the presence of GDP, while Byrnes and Sondermann46 found only 
monomers with GDP. SAXS analysis also supported a monomer in the presence of 
GDP. This apparent discrepancy may be explained by different experimental 
conditions such as protein or nucleotide concentration. We detected only 
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monomeric atl (1-422) with GDP and equilibrium binding data (Figure4-3c) suggest 
that the concentration of GDP used in our analysis should be sufficient for atl (1-
422) to bind the GDP. 
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Chapter 5 
Atlastin Mediated Membrane Fusion 
requires GTPase hydrolysis 
5.1. Characterization of GTPase activity 
Atlastin belongs to the superfamily of dynamin-like GTPasesso. It has been 
established that ER membrane fusion requires GTP12 and that atlastin is a GTPase 
directly responsible for fusion. Additionally, many of the HSP causing mutation lie 
in the GTPase domain of atlastin (Table 5-1) While it is clear the GTP domain of 
atlastin is essential to its function in promoting ER membrane fusion we know very 
little regarding the enzymatic properties of atlastin and it remains unclear how GTP 
binding and hydrolysis is translated into fusion. 
To address these issue, we measured Michaelis-Menten kinetics for full-
length GST -atlastin in detergent and reconstituted into proteoliposomes using a 
coupled enzymatic assay that quantifies inorganic phosphate production. This assay 
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includes purine nucleoside phosphorylase (PNP) which consumes the free 
phosphate released by the GTPase activity of atlastin and couples this consumption 
with a detectable output by phosphorylating another substrate, MESG, producing 
ribose-5-phosphate and 2-amino-6-mercapto-7 -methyl purine which has 
measurable absorbance at 360 nm (Figure 2-2). Using this coupled assay I can 
detect continuous production of phosphate from GTPase activity. I insured that 
quantifying inorganic phosphate production was a reliable measure of GTPase 
activity by examining all of the guanine nucleotide reaction products by HPLC 
(Figure 5-la) since GBP1, another large GTPase family member similar in sequence 
to atlastin, is capable of sequentially cleaving GTP to GMP49. 
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(A)Aliquots of a GTPase reaction containing 0.5 mM GTP and 5 11M atl (1-422) from various time 
intervals were analyzed by HPLC. Atlastin show only GOP production. Standards of 0.5 mM GMP, 
GOP, and GTP were run over the column and showed peak retention times of 1.85 min, 4.4 min, and 
12 min, respectively. (B) Michaelis-Menten kinetics of GST-atlastin in detergent compared to GST-
atlastin reconstituted into liposomes and GST-atlastin (1-422). Full-length GST-atlastin shows about 
a 2.5 to 3-fold increase in Vmax when reconstituted into liposomes and the free cytoplasmic domain 
has an even greater activity (5- to 6-fold over WT in detergent). The Michaelis-Menten parameters 
are listed in a table inset. Error bars, SEM. 
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liposomes I plotted the initial velocities versus GTP concentrations and determined 
the Km and Kcat ofWT atlastin and atlastinl-422 (Figure 5-1 b). Surprisingly, we 
observed that reconstitution significantly improved the maximum velocity of this 
enzyme even though the amount of enzyme assayed in proteoliposomes is half (0.5 
11M) of that in detergent (111M). GTPase activity is increase while there is little 
difference in the binding affinities between atlastin in detergent and in liposomes. 
These data demonstrate that atlastin is a more active enzyme in a phospholipid 
bilayer compared to a detergent micelle. The most straightforward interpretation of 
this activity increase is that atlastin has an improved ability to dimerize in the plane 
of a membrane following reconstitution (a cis-dimer) or that trans dimerization 
between liposomes stimulates GTPase activity. 
Next, I examined the activity of theN-terminal cytoplasmic domain, atl (1-
422). TheN-terminal cytoplasmic domain displayed stimulated activity even 
greater than that seen in reconstituted full length protein (Figure 5-1b and Figure 4-
3)) suggesting that the regions of atlastin responsible for oligomerization and 
enzymatic activation reside in this domain. Given that other large GTPases like 
dynamin and GBP1 dimerize through contacts within the G-domain, we produced an 
additional construct that expressed the isolated GTPase domain, atl (1-328). 
However, we found that the GTPase domain alone was not sufficient to produce an 
active enzyme at the same concentration (0.5 11M) as the other protein examined 
(Figure 4-3). The atl (1-328) protein is not simply a misfolded protein because it 
shows a concentration dependent increase in at activity higher GTP concentrations 
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(Figure 4-3). These results suggest that the GTPase domain alone is not sufficient to 
provide a stable interaction platform for GTP hydrolysis. 
5.2. GTP hydrolysis is required for fusion 
While it is clear that atlastin is a functional GTPase it is unclear whether GTP 
hydrolysis or binding or both is required for atlastin-mediated membrane fusion . 
Co-immunoprecipitation of HA- and Myc-tagged atlastin expressed in He La 
cells showed that atlastin-HA was co-immunoprecipitated by anti-myc antibodies 
(Figure 5-2a) and the addition of 1 mM GTP or GTPyS to celllysates resulted in a 3-
fold increase in complex formation between atl-myc and atl-HA (Figure 5-2a). This 
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Figure 5-2: GTPyS enhances atlastin self-association but inhibits ongoing liposome fusion. 
(A) Co-immunoprecipitation oftransfected atlastin-HA and atlastin-myc was performed in 
the absence of exogenous nucleotide or presence of 1 mM GTP or GTPyS. (B) Quantification of the 
data from five independent co-immunoprecipitation experiments shows that the presence of GTP 
and GTPyS increase atlastin complex formation. (C) Addition of 0.5 mM GTPyS to an ongoing 
liposome fusion reaction rapidly blocks fusion. Error bars represent S.E.M. Panels A&B by Diana 
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(A) GTPase activity of 111M GST-tagged protein in detergent. The active site mutations, KSlA 
and R48E, incompletely reduce GTPase activity. Error bars, SEM. (B) Binding to mant-GTPyS 
with increasing amounts of GST-tagged atlastin mutants. The KSlA mutant has a reduced 
binding affinity to nucleotide (Kd = 134 11M) compared to WT and the R48A mutant(~= 2.3 11M 
and 5.6 11M, respectively. Data were fit with a global Fmax (see methods). (C) Neither of the 
GTPase domain mutants is able to promote membrane fusion. 
is in agreement with the dimerization of atlastin (1-422) in the presence of GTPyS 
(Figure 4-1 ). Curiously while GTPyS increases atlastin association in vivo and in 
vitro is has been shown to inhibit in vitro ER reformation12. In vitro fusion results 
also show that GTPyS is unable to support fusion (Figure 3-3 and Figure 3-5). 
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Furthermore, addition of GTPyS to an ongoing fusion reaction abruptly and potently 
inhibits fusion (Figure 5-2). These data suggest that nucleotide binding is not 
enough to promote fusion. Oligomerization and possibly docking of liposomes is 
likely supported by GTP binding and GTP hydrolysis must ensue for fusion to occur. 
Point mutations within the GTPase domain of atlastin agree with this 
hypothesis. A lysine to alanine mutation at residue 51 (K51A) within the active site 
of atlastin results in reduced GTPase activity and GTP binding (Figure 5-3 a&b) 
showing about a roughly 60-fold decrease in binding affinity compared to WT while 
an arginine to alanine mutation at reside 48 (R48A) had little effect upon binding 
affinity (Figure 5-3b ). Even though the atlastin R48A mutant binds GTP similar to 
wild type it is deficient in GTP hydrolysis and ineffective in promoting the fusion of 
liposomes supporting the idea that nucleotide binding alone is insufficient to 
support fusion. Atlastin must hydrolyze GTP to fuse membranes. 
Table 5-1: HSP mutations in atlastin-1 and analogous residues in Drosphila atlastin 
Hs-Atll Dm-Atl Domain Hs-Atll Dm-Atl Domain Hs-Atll Dm-Atl Domain 
K80A KSl GTPase H247R!>1 H222 GTPase M408TL M383 3-helix 
F151S53 F126 GTPase L250P52 L225 GTPase F413L54 F388 3-helix 
Tl561 55 Tl31 GTPase Q251K54 Q226 GTPase R415W56 £390 3-helix 
L157W57 V132 GTPase V2531 54 L228 GTPase 6N43658 N411 3-helix 
A161P59 A136 GTPase H258R15 5233 GTPase N440T54 N415 3-helix 
Tl62P22 T137 GTPase S259F51 S234 GTPase Y459C60 Y434 TMD 
A165T1 A140 GTPase S259Y15 S234 GTPase G469A52 G444 TMD 
H189D7 H164 GTPase 1315S53 1290 GTPase G482V52 G457 TMD 
Q191R52 Q166 GTPase Y336H 52 Y311 GTPase A492fsX52252 A467 STOP 
R217Q61 R192 GTPase C375R 22 C350 3-helix R495W62 R470 STOP 
R239C15 R214 GTPase S398Y53 A373 3-helix ES02fsXS2263 0477 STOP 
R239L51 R214 GTPase S398F64 A373 3-helix 1507fsX52265 L482 STOP 
H247P59 H222 GTPase M408V66 M383 3-helix S519N54 M494 unknown 
5.3. Pathological mutations within the GTPase domain reduce 
GTPase activity and fusion activity 
Unsurprisingly, the majority of the disease-causing alleles of SPG3A fall 
within the GTPase domain of atlastin (Table 5-l ). Analogous mutation of two such 
alleles R239C and S259Y were made in Drosophila atlastin, R214C and S234Y. I 
measured the GTPase activity of these two alleles and found that R214C showed 
reduced GTPase activity (Figure S-4). Surprisingly, although the GTPase activity 
was reduced to nearly the same degree as the R48A mutation, this /(pathological" 
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Figure 5-4: GTPase and fusion activity of pathological mutants. 
Mutations within the GTPase domain of fly atlastin analogous to pathological mutations identified in 
humans show reduce GTPase activity (0.5 mM GTP, 1 11M protein). The pathological mutants are able 
to support some degree of fusion despite the reduced GTPase activity. 
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mutant was able to support fusion proportional to its level of GTPase activity. The 
S234Y mutation behaved similarly to wildtype in both GTPase activity and extent of 
fusion. This reflects that although there is strong conservation in sequence in the 
GTPase domain from fly atlastin to human atlastin, comparison of results between 
the two should be made with caution. 
5.4. Conclusions 
Data from the nonhydrolyzable nucleotides and point mutations agree that 
GTP binding and dimerization of atlastin are not enough to promote fusion. GTP 
hydrolysis and likely a conformation change are required to promote fusion. This 
suggests that atlastin dimerization upon nucleotide binding occurs through the 
GTPase domain alone and assume the shape of the form 2 dimer (Figure 4-4). 
However, the AUC data shows that stable dimerization requires the middle domain 
similar to the form 1 dimer (Figure 4-4). However, both of these experiments are 
done with a truncated form of atlastin where the 3HB is freer to assume either 
dimerform. 
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Chapter 6 
The middle-domain three-helix bundle 
plays and important role in atlastin 
function 
6.1. Proline mutations within the middle domain 3-helix bundle 
disrupt atlastin function 
The middle domain of atlastin forms a 3-helix bundle (3HB) that provides a 
strong interaction surface in the form 1 crystal structure (Figure 4-4). This 3HB is 
important in forming or stabilizing a dimer in the Drosophila atlastin N-terminal 
cytoplasmic domain (Figure 4-1). Additionally, GTPase activity is impaired in a 
soluble domain lacking the 3HB, atlastin (1-328). The importance of the 3HB in the 
context of full-length atlastin was done by introducing proline-mutations that would 
disrupt the a-helical nature of this domain. I purified and reconstituted full-length 
atlastin with proline mutations at residues leucine 400 and phenylalanine 404, 
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L400P and F404P respectively. I tested the affect these mutations have upon 
GTPase activity and the ability to promote fusion. 
When tested for fusion both proline mutations were unable to promote 
fusion (Figure6-1 ). The GTPase activity of atlas tin is increased when atlastin is 
reconstituted into a lipid bilayer (Figure 5-1). This may be due to the cooperative 
nature of large GTPases. The self-association of atlastin monomers would likely be 
increased when restricted to the plane of the lipid bilayer resulting in increased 
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Figure 6-1: Proline mutations in the 3-helix bundle disrupt atlastin function 
(A) Cartoon schematic showing the location of the proline mutations in the 3HB domain. (B) The 
3HB proline mutants cannot fuse liposomes. (C) The reconstitution induced stimulation in 
GTPase activity is dependent upon the 3HB domain. Wild type atlastin shows a 2.5-3 fold increase 
in GTPase activity when in liposomes while the F404P atlastin mutant does not show any increase 
in activity. Errors bars, SEM. 
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GTPase activity. This hypothesis would predict that if homooligomerization were 
disrupted there would be no increase in GTPase activity upon reconstitution. There 
is no increase in GTPase activity when the atlastinF404P mutant is reconstituted into 
liposomes (Figure 6-1) 
6.2. The full-length soluble domain of atlastin is a potent 
inhibitor of atlastin mediated membrane fusion 
All membrane fusion proteins characterized to date require membrane 
integration. However, liberated soluble domains that retain the ability to 
productively interact with membrane integral components are often inhibitors of 
fusion. This is definitely the case for SNARE proteins and inclusion of a soluble 
fragment of either v-SNARE or t-SNARE component will inhibit fusion37,67. I tested 
the functionality of C-terminal truncations that lack a membrane spanning domain 
by determining their capacity to inhibit fusion between proteoliposomes that 
contain wildtype atlastin. I tested atlastin (1-422) that encompassed the entire N-
terminal cytoplasmic domain and atlastin (1-328) that contains the isolated GTPase 
domain. When atlastin (1-422) was titrated into a fusion reaction containing 
wild type atlastin in the membrane, progressive inhibition of both the rate and 
extent of membrane fusion is seen (Figure 6-2). Inhibition was concentration 
dependent and fusion was completely inhibited with a 6-fold molar excess of the 
atlastin (1-422) soluble domain. While the full-length N-terminal cytoplasmic 
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Figure 6-2: Atlastin soluble domain inhibiton of atlastin mediated fusion 
(A) Cartoon schematic of atlastin fragments purified and added acutely to fusion 
reactions between GST-atlastin proteoliposomes (Band C). (B) Atlastin (1-422) 
inhibits fusion in a dose dependent manner and completely inhibits fusion at a 6 
molar excess of protein. (C) Atlastin (1-328) shows minimal inhibition of fusion 
over the same range of concentrations. 
domain was a potent inhibitor, the isolated GTPase domain (atl (1-328)) was 
ineffective in inhibited fusion. 
6.3. The proximity of the 3HB to the transmembrane domains is 
important for fusion activity 
Association of the 3HB is important for the fusogenicity of atlastin. The 
association of the two 3HBs in the form 1 crystal structure (Figure 4-4) would 
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Figure 6-3: Insertion of a juxtamembrane flexible linker reduces the fusogenicity of atlastin 
(A) Schematic representation of the location of the insertion of a flexible linker between the 3HB 
and the transmembrane domains. (B) Fusion is decreased when wildtype unlabeled liposomes 
are fused with linker mutant liposomes (asterisk denotes labeled liposomes). Fusion is further 
decreased when both populations of liposomes contain the mutant protein. (C) The atlastin linker 
mutant has similar GTPase activity to wild type. Error bars, SEM. 
require very close apposition of distinct bilayers in a trans-dimer forcing fusion to 
occur so that the two subunits reside in the same bilayer (cis-dimer). To test the 
importance of the proximity of the base of the 3HB to the membrane a flexible 3X 
Gly-Gly-Ser-linker was inserted in the juxtamembrane region between proline -423 
and alanine-424 (Atlastin(lxlinker), Figure 6-3) to distance the 3HB from the 
membrane. A similar mutation was made in the SNAREs syntaxinla and Vamp2. 
These flexible linkers reduce the ability of SNARES to promote fusion 68, by 
uncoupling the energy release by formation of the ternary SNARE complex from 
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being transduced through the transmembrane domain into the lipid bilayer. The 
atlastin (1xlinker) has reduced ability to fuse liposomes (Figure 6-3). 
6.4. Conclusions 
The middle domain 3HB of atlastin is important in mediating stable self-
association of atlastin. Disruption of the 3HB results in a reduction in GTPase 
activity and a loss of fusogenic ability (Figure 6-1). Soluble domain inhibition 
studies show that the GTPase domain alone lacking the 3HB is insufficient to 
mediate tight association. However the full-length N- terminal cytoplasmic domain 
including the 3HB binds tightly and is a potent inhibitor of atlastin proteoliposomes 
fusion (Figure 6-2). The proximity of the 3HB to the membrane is important. 
Formation of trans-dimers that tightly associate through the 3HB are important in 
efficient membrane fusion as when the 3HB is distanced from the membrane via a 
flexible linker fusion is impaired (Figure 6-3). 
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Chapter 7 
The C-terminal cytoplasmic domain 
7.1. The C-terminal cytoplasmic domain ofatlastin is required 
for fusion 
To explore the requirement of other domains of atlastin we made several 
large truncations at the C-terminus. We started making deletions from the C-
terminal end as we have shown that GTPase activity is required for fusion and the 
GTPase domain is found near theN-terminus. We produced truncations that 
removed the entire C-terminal cytoplasmic domain (residues 472-542) and the 
second transmembrane domain as well as the C-terminal cytoplasmic domain 
(residues 451-542). Both resulting atlastin fragments, atlastin (1-450) and atlastin 
(1-471), retain an intact GTPase domain and at least one transmembrane 
anchor(Figure 7-1a). We expressed these proteins in E. coli and reconstituted them 
into synthetic PCPS liposomes and measured membrane fusion by lipid mixing. 
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Figure 7-1: C-terminal truncations ofatlastin are unable to fuse liposomes 
(A) Domain structure of atlastin and the c-terminal truncations. (B) Kinetic 
fusion graph of unlabeled atlastin acceptor proteoliposomes fused with 
equimolar amounts of fluorescently labeled atlastin donor proteoliposomes 
(Inset) The average extent of fusion at 60 min is represented in a table as 
percent ofWT fusion for all mutants. (C) GTPase activity of all the mutants. 
Error bars, SEM. 
When either of these two proteins was reconstituted into proteoliposomes, no 
fusion was observed (Figure 7-1b). The functionality of these enzymes was 
confirmed by examining GTPase activity (Figure 7-1c). Both 1-450 and 1-471 were 
able of cleaving GTP at rates that were within 25% of wild type. These results 
suggest that the C-terminal cytoplasmic domain of atlastin is critical for membrane 
fusion. 
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The C-terminal truncation, atlastin (1-471), was also assayed for its fusogenic 
ability in vivo. Cos7 cells overexpressing wild type atlastin have an abnormal 
punctate ER (Figure 7-2a,b&c). When overexpressing atlastin (1-471) the cells have 
a normal ER phenotype suggesting it is a non-functional protein (Figure 7-2d,e&t). 
The C-terminal domain of atlastin is among the most divergent between 
Figure 7-2: Deletion of c-terminal domain results in a non-functional protein in vivo. 
Cos? cells were cotransfected with wildtype atl-myc (A-C), atl (1-471)-myc (D-F), or atl (1 -
497)-myc (G-1) and GFP-Sec61~. Wildtype atl and atl (1-497) show an abnormal, punctate ER 
indicating a functional Drosophila atlastin protein, while atl (1-4 71) localizes to a normally 
reticular ER suggesting that it is a nonfunctional protein. Scale bar, 10 IJ.m. Data by D. Pendin 
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atlastin homologs and paralogs. Closer inspection of the sequences that comprise 
the C-terminal cytoplasmic domain revealed an approximately 25 amino acid 
stretch of more highly conserved residues membrane proximal to the second 
transmembrane domain followed by a very divergent extreme C-terminus. We 
further subdivided the C-terminal cytoplasmic domain to add back the more 
conserved juxtamembrane region (residues 471-497). The resulting construct (1-
497) was also expressed, reconstituted and assayed for membrane fusion. Figure 7-
1 demonstrates that the reintroduction of these 27 residues restores approximately 
75% ofwildtype fusion activity and Cos7 cells overexpressing atlastin (1-479) have 
a punctate ER (Figure 7-2g,h&i) similar to wildtype atlastin overexpression. 
7 .2. Conclusions 
In vitro (Figure 7-1) and in vivo (Figure 7-2) data suggest a short region of 
approximately 27 amino acids located within the cytoplasmic C-terminal domain are 
critically required for atlastin-dependent membrane fusion. Interestingly, three 
frame shift mutations in human Atlastin-1, A492fsX522, E502fsX522, and 
I507fsX522 (Table 5-1), known to cause hereditary spastic paraplegia, prematurely 
truncate Atlastin-1 and scramble the C-terminal juxtamembrane region that we 
have shown is required for membrane fusion. 
While the function of this region is unclear, the C-terminal region appears to 
show a propensity to form amphipathic helices (Figure 7-3). Additionally, 
preliminary data show that introduction of charged residues in the hydrophobic 
face of a putative amphipathic a-helix disrupts fusion (Figure 7-4a). Also, swapping 
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out the entire C-terminal region of fly atlastin with an analogous region from human 
atlastin-1 or -3 results in a fusogenic chimaera. This suggests that this region does 
not have a specific interaction and probably has a propensity to interact with the 
adjacent lipid bilayer, 
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Figure 7-4: Preliminary data of c-tail mutants and human c-terminal domain swaps. 
(A) Kinetic fusion graph of GST-atlastin, GST-atlastin (F478K), or GST-atlastin (L482K). Charge 
mutations at targeted positions within the c-terminal domain abolish atlastin fusogenicity. (B) 
Kinetic fusion graph ofliposomes bearing wildtype atlastin or atlastin mutants that swapped out the 
the c-terminal domain of atlastin for the respective sequence of human atlastin 1 and atlastin 3 
isoforms. 
Chapter 8 
Discussion 
8.1. Model of atlastin mediated fusion 
Membrane fusion by atlastin likely involves many steps. The schematic 
shown in Figure 8-1 describes our working model for atlastin function. Atlastin 
almost entirely faces the cytoplasm with as few as 5 residues in an ER luminal loop. 
We suggest that the fusion cycle begins with nucleotide-free atlastin monomers 
(Figure 8-1a ) in opposing ER membranes. These monomer forms are cartooned as 
the "pre-fusion" (31) or crystal form 2 structures (34). Then we suggest that 
nucleotide binding (Figure 8-1b) results in a permissive state for association 
between the GTPase domains (Figure 8-1c ). TheN-terminal cytoplasmic domain of 
Drosophila atlastin (Atl (1-422)) forms a dimer when bound to nonhydrolyzable 
GTPyS but not with GDP (Figure 4-1). We assume that this association also occurs in 
the context of full length atlastin. While this interaction between the GTPase 
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Figure 8-1: Working model ofatlastin mediated membrane fusion 
domains is presumably a required intermediate, its stability may be limited. We 
propose that the interaction between GTPase domains matures to a more stable 
dimer facilitated primarily by an interaction between the middle domain three 
helical bundle segments (Figure 8-1d). This conformational change is achieved, 
perhaps driven by nucleotide hydrolysis, by rotating the GTPase domain dimer 180 
degrees which forces the three-helix bundles into close proximity. The new 
association between adjacent 3HBs liberates the (-terminal tail domain to perform 
its required role. We have localized this required function to a region of 27 amino 
acids immediately adjacent to the second transmembrane span (Figure 7-1). The 
activity of this (-terminal domain may be accomplished by forming a new 
association with the dimeric 3HB or by direct interaction with lipid (Figure 8-1d). 
We currently favor a direct interaction with lipid based on the amphipathic nature 
of this protein sequence (Figure 7-3). An interaction between the membrane 
surface and the amphipathic (-terminal tail could destabilize the bilayer and 
provide the driving force for outer leaflet mixing, resulting in a hemifusion 
intermediate (Figure 8-1e) that resolves by inner leaflet mixing to full fusion (Figure 
8-lf). The resulting cis-dimer resembles the "post fusion"48 or crystal form 1 
structure46. Finally, we hypothesize that GD~ release could then promote 
dissociation. 
Although, the precise location and timing of GTP hydrolysis during the cycle 
is speculative, some biochemical experiments can be used to place constraints on 
the model. We suggest that the large conformational change postulated to occur 
following docking (Figure 8-lc&d) utilizes the energy provided by GTP hydrolysis. 
However our oligomerization data suggest that GTPyS, but not GDP, results in the 
stable dimeric conformation cartooned in Figure 8-ld when soluble fragments are 
examined, indicating that this intermediate may contain bound GTP. Functional 
analysis revealed that GTP hydrolysis is required to fuse proteoliposomes in vitro 
since GTPyS does not support fusion4o. These lipid mixing results demonstrate that 
nucleotide hydrolysis is required prior to hemifusion; however, we cannot exclude 
the possibility that events downstream of GTP hydrolysis, for example inorganic 
phosphate release, play an important role4s. 
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